Basel, Switzerland

Ronald Gieschke

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: F. Hoffmann-La Roche Ag, Prothena Biosciences Limited. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ronald Gieschke

Introduction

Ronald Gieschke is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of synucleinopathies. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Ronald Gieschke holds a patent titled "Dosing Regimes for Treatment of Synucleinopathies." This patent represents his commitment to advancing medical treatments and improving patient outcomes. He has 1 patent to his name, showcasing his innovative approach to addressing complex health challenges.

Career Highlights

Throughout his career, Ronald has worked with prominent companies in the pharmaceutical industry. He has been associated with F. Hoffmann-La Roche AG and Prothena Biosciences Limited. His experience in these organizations has allowed him to collaborate with leading experts in the field.

Collaborations

Ronald Gieschke has worked alongside talented individuals such as Jay Soto and Daniel Keith Ness. These collaborations have contributed to the advancement of his research and the successful development of his patent.

Conclusion

In summary, Ronald Gieschke is an accomplished inventor whose work in the treatment of synucleinopathies has made a significant impact in the medical field. His innovative spirit and dedication to improving health outcomes are commendable.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…